Longenesis 2024 Wrap-Up! 🌟 💯 As 2024 comes to a close, we’re taking a moment to look back at the most memorable milestones that made this year unforgettable! While highlighting the big ones, what truly made this year pass by so quickly were the small, daily victories that boosted us to win big! Check out the letter from our CEO Emil, highlighting the team, our partners and clients! 👇
I am happy to see that this year at Longenesis can be called a year of commercial and product development results with our solutions empowering more than 850,000 patients and counting! Some of the quotes we've seen on our company this year: "Technology brought by Longenesis will be more than just a technological solution - it will be a model for modern cardiovascular disease treatment" "Latvian startup dominates Supernova Challenge 2.0 with $100,000 victory for its innovative Health Tech solutions" In 2024 we have pivoted and validated our focused value proposition with Life Science and Healthcare Institutions, leading to a Product-Market-Fit (PMF) and positive commercial results. Our team has successfully secured commercial traction with Life Science companies and Healthcare Institutions in Europe and GCC. All this helped us in leading the company to profitability and positive growth in the long run. Here is our 2024 in a nutshell - recognizing the team, our partners, and clients for the value brought to healthcare through digital solutions: Thank you, team! Justīne Elferte, Arnolds Bogdanovs, Agate Kalcenaua, Ieva Danovska, Ilva Kononova, Martins Mednis, Juris Ruseckis, Dārta Maija Zaķe, Lonija Kazlauska, Markuss Zabello, Daniels Pavluts, Agnese Veckalne-Lescinska, Renda Forstmane, Zaiga Kluine, Lilian Tzivian